TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+2.58%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$107B
AUM Growth
-$263M
(-0.24%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
25.85%
Holding
1,451
New
70
Increased
678
Reduced
517
Closed
90
Top Buys
| 1 |
Apple
AAPL
|
$328M |
| 2 |
Exxon Mobil
XOM
|
$206M |
| 3 |
Danaher
DHR
|
$169M |
| 4 |
Carlisle Companies
CSL
|
$109M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$108M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$223M |
| 2 |
NVIDIA
NVDA
|
$184M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$184M |
| 4 |
Accenture
ACN
|
$137M |
| 5 |
Visa
V
|
$115M |
Sector Composition
| 1 | Technology | 21.93% |
| 2 | Financials | 18.71% |
| 3 | Healthcare | 11.45% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
1401
Mereo BioPharma
MREO
$275M
| – | – |
-148,000
| Closed | -$488K |
|
1402
Nice
NICE
$8.56B
| – | – |
-225,869
| Closed | -$58.9M |
|
1403
Northern Oil and Gas
NOG
$2.54B
| – | – |
-16,600
| Closed | -$659K |
|
1404
NOV
NOV
$4.96B
| – | – |
-17,502
| Closed | -$342K |
|
1405
Intellia Therapeutics
NTLA
$1.25B
| – | – |
-30,692
| Closed | -$844K |
|
1406
Nuvation Bio
NUVB
$1.17B
| – | – |
-154,200
| Closed | -$561K |
|
1407
Nuvalent
NUVL
$5.74B
| – | – |
-12,878
| Closed | -$967K |
|
1408
Northwest Bancshares
NWBI
$1.88B
| – | – |
-50,400
| Closed | -$587K |
|
1409
Patrick Industries
PATK
$3.8B
| – | – |
-5,400
| Closed | -$430K |
|
1410
Preferred Bank
PFBC
$1.19B
| – | – |
-4,600
| Closed | -$353K |
|
1411
Primerica
PRI
$8.87B
| – | – |
-6,430
| Closed | -$1.63M |
|
1412
Perimeter Solutions
PRM
$3.26B
| – | – |
-21,188
| Closed | -$157K |
|
1413
Gores Guggenheim
PSNY
$2.2B
| – | – |
-20,400
| Closed | -$31.4K |
|
1414
P10
PX
$1.34B
| – | – |
-116,940
| Closed | -$985K |
|
1415
Resources Connection
RGP
$169M
| – | – |
-68,700
| Closed | -$904K |
|
1416
Robert Half
RHI
$3.8B
| – | – |
-29,250
| Closed | -$2.32M |
|
1417
Rio Tinto
RIO
$101B
| – | – |
-662,144
| Closed | -$42.2M |
|
1418
Roivant Sciences
ROIV
$8.58B
| – | – |
-91,192
| Closed | -$961K |
|
1419
RxSight
RXST
$347M
| – | – |
-17,140
| Closed | -$884K |
|
1420
Southside Bancshares
SBSI
$944M
| – | – |
-15,290
| Closed | -$447K |
|
1421
SiriusXM
SIRI
$7.94B
| – | – |
-36,851
| Closed | -$1.43M |
|
1422
SK Telecom
SKM
$8.32B
| – | – |
-9,747
| Closed | -$210K |
|
1423
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-30,760
| Closed | -$732K |
|
1424
Titan International
TWI
$560M
| – | – |
-60,100
| Closed | -$749K |
|
1425
UroGen Pharma
URGN
$870M
| – | – |
-32,800
| Closed | -$492K |
|